People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Other, Pharmaceuticals, Computers, Other Health Care, AI / ML, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Atieva, Inc. | — | Other | Series D+ | $307.1M | $3.1B | 2021 |
| InfraScale, Inc. | — | Other | Series A | $29.4M | $24.2M | 2013 |
| Rational Vaccines, Inc. | — | Pharmaceuticals | Series A | $27.8M | $363.5M | 2020 |
| Bridg, Inc. | — | Computers | Series A | $13.3M | $370.8M | 2017 |
| Seven Springs Orthopaedics Management, Inc. | — | Other Health Care | Series A | $7.3M | $13.0M | 2018 |
| SOS Online Backup, Inc. | — | Other | Seed | $3.5M | $13.9M | 2011 |
| Get Together AI, Inc. | — | AI / ML | Seed | $2.8M | $17.6M | 2024 |
| Hyver Labs, LLC | — | Software / Tech | Pre-Seed | $1.4M | $34.8M | 2018 |
| R-Squared Services & Solutions, Inc. | — | Other Technology | Pre-Seed | $250K | $10.6M | 2010 |
MICHAEL BELL at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside MICHAEL BELL on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| KENNETH SHAW, SR. | 2 | 2 |
| Daniel Gregerson | 2 | 2 |
| KENNETH SHAW, JR. | 2 | 2 |
| Robert Brown | 1 | 22 |
| Landon Gibbs | 1 | 12 |
| JAMES ARMSTRONG | 1 | 10 |
| Amit Jain | 1 | 7 |
| Joseph Miller | 1 | 7 |
| Jason Camm | 1 | 5 |
| Christopher Booker | 1 | 5 |
| Michael Horowitz | 1 | 4 |
| Anthony Posawatz | 1 | 3 |
| Andrew Page | 1 | 3 |
| Cameron Perkins | 1 | 3 |
| Beatriz Infante | 1 | 2 |
| Peter Rawlinson | 1 | 2 |
| Reagan Sakai | 1 | 2 |
| Michael Smuts | 1 | 2 |
| Eric Bach | 1 | 2 |
| MARC McMORRIS | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.